Syvälahti E - Search Results

1

Effect of tuberculostatic agents on the response of serum growth hormone and immunoreactive insulin to intravenous tolbutamide, and on the half-life of tolbutamide.

Syvälahti E, Pihlajamäki K, Iisalo E. Syvälahti E, et al. Int J Clin Pharmacol Biopharm. 1976 Mar;13(2):83-9. Int J Clin Pharmacol Biopharm. 1976. PMID: 1254383

2

Letter: Rifampicin and drug metabolism.

Syvälahti EK, Pihlajamäki KK, Iisalo EJ. Syvälahti EK, et al. Lancet. 1974 Jul 27;2(7874):232-3. doi: 10.1016/s0140-6736(74)91547-5. Lancet. 1974. PMID: 4135664 No abstract available.

3

Cardioselective (metoprolol) and non-selective (propranolol) beta-blockade and glucose homeostasis.

Syvälahti E, Lammintausta R, Iisalo E, Kanto J. Syvälahti E, et al. Ann Clin Res. 1977 Oct;9(5):292-5. Ann Clin Res. 1977. PMID: 616215 Clinical Trial.

4

Growth hormone and insulin secretion in oophorectomized women.

Syvälahti E, Erkkola R, Iisalo E, Punnonen R, Rauramo L. Syvälahti E, et al. Horm Metab Res. 1975 Sep;7(5):438-9. doi: 10.1055/s-0028-1095671. Horm Metab Res. 1975. PMID: 1183926 No abstract available.

5

The effect of practolol on circulatory response after sympathetic stimulation and on plasma growth hormone and insulin levels.

Syvälahti E, Iisalo E, Leppänen O. Syvälahti E, et al. Ann Clin Res. 1974 Oct;6(5):258-65. Ann Clin Res. 1974. PMID: 4217121 Clinical Trial. No abstract available.

6

Human pharmacokinetics of nitrazepam: effect of age and diseases.

Kangas L, Iisalo E, Kanto J, Lehtinen V, Pynnönen S, Ruikka I, Salminen J, Sillanpää M, Syvälahti E. Kangas L, et al. Among authors: syvalahti e. Eur J Clin Pharmacol. 1979 Apr 17;15(3):163-70. doi: 10.1007/BF00563100. Eur J Clin Pharmacol. 1979. PMID: 456400

7

Noradrenergic and dopaminergic effects of nomifensine in healthy volunteers.

Scheinin M, Lindberg R, Syvälahti E, Hietala J, Pihlajamäki K, Scheinin H. Scheinin M, et al. Among authors: syvalahti e. Clin Pharmacol Ther. 1987 Jan;41(1):88-96. doi: 10.1038/clpt.1987.15. Clin Pharmacol Ther. 1987. PMID: 3802712

8

Disposition of nomifensine after acute and prolonged dosing.

Lindberg RL, Syvälahti EK, Pihlajamäki KK. Lindberg RL, et al. Among authors: syvalahti ek. Clin Pharmacol Ther. 1986 Apr;39(4):384-8. doi: 10.1038/clpt.1986.59. Clin Pharmacol Ther. 1986. PMID: 3956055

9

Growth hormone and cortisol secretion after oral and intravenous administration of methyldopa.

Syvälahti E, Seppälä PO, Iisalo E. Syvälahti E, et al. Acta Pharmacol Toxicol (Copenh). 1975 Sep;37(3):257-64. doi: 10.1111/j.1600-0773.1975.tb00843.x. Acta Pharmacol Toxicol (Copenh). 1975. PMID: 1103571 Clinical Trial. No abstract available.

10

Serum growth hormone, serum immunoreactive insulin and blood glucose response to oral and intravenous diazepam in man.

Syvälahti EK, Kanto JH. Syvälahti EK, et al. Int J Clin Pharmacol Biopharm. 1975 Jul;12(1-2):74-82. Int J Clin Pharmacol Biopharm. 1975. PMID: 1100541 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page